SAI
GILD icon

Savvy Advisors Inc’s Gilead Sciences GILD Stock Holding History

Savvy Advisors Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Buy
15,259
+3,857
+34% +$508K 0.04% 341
2026
Q1 		$1.59M Buy
11,402
+2,596
+29% +$364K 0.04% 321
2025
Q4 		$1.08M Buy
8,806
+3,216
+58% +$391K 0.03% 349
2025
Q3 		$620K Buy
5,590
+995
+22% +$113K 0.03% 383
2025
Q2 		$509K Buy
4,595
+1,670
+57% +$178K 0.03% 345
2025
Q1 		$328K Buy
2,925
+589
+25% +$60.8K 0.03% 371
2024
Q4 		$216K Buy
+2,336
New +$210K 0.03% 415

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Savvy Advisors Inc's GILD Position: Q2 2026 in Review

Savvy Advisors Inc increased its Gilead Sciences (GILD) stake by 34% in Q2 2026, buying an estimated $508K and bringing the position to 15,259 shares worth $1.93M. The position accounts for 0.04% of the portfolio, ranked #341.

Savvy Advisors Inc first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Savvy Advisors Inc held 15,259 shares of Gilead Sciences worth $1.93M as of Q2 2026.
  • Savvy Advisors Inc bought 3,857 Gilead Sciences shares in Q2 2026, an estimated $508K.
  • Gilead Sciences made up 0.04% of Savvy Advisors Inc's portfolio in Q2 2026, its #341 holding.
  • Savvy Advisors Inc first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.